Hyperfine (HYPR) vs Vivani Medical (VANI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Vivani Medical (VANI) has outperformed Hyperfine (HYPR) over the past year, losing 10.9% versus a loss of 55.0%. Over five years, VANI leads with a -86.0% price change compared with -90.5% for HYPR. Vivani Medical is the larger company by market cap ($111.0 million vs $99.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HYPR | VANI |
|---|---|---|
| Share price | $0.9401 | $1.23 |
| Market cap | $99.70M | $110.95M |
| 1-day change | +10.73% | -3.15% |
| YTD return | -3.97% | 0.00% |
| 1-year return | -55.02% | -10.87% |
| 5-year return | -90.54% | -85.96% |
| EPS (TTM) | $-0.37 | $-0.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.22 | $1.92 |
| 52-week low | $0.754 | $0.923 |
| Distance from 52-week high | -57.65% | -35.94% |
| Analyst consensus | none | none |
| Avg. price target upside | +115.93% | +211.38% |
| Average volume | 611.89K | 243.63K |
| Shares outstanding | 90.99M | 90.20M |
| Employees | 102 | 42 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- VANI has outperformed HYPR by 44.1 percentage points over the past year.
About Hyperfine
HYPR stock →Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners.
Healthcare · Medical Devices · 102 employees
About Vivani Medical
VANI stock →Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases.
Healthcare · Biotechnology · 42 employees
HYPR vs VANI FAQ
Which is bigger, Hyperfine or Vivani Medical?
Vivani Medical (VANI) is larger, with a market capitalization of $110.95M compared with $99.70M for Hyperfine (HYPR).
Which stock has performed better over the past year, HYPR or VANI?
VANI returned -10.87% over the past 12 months, compared with -55.02% for HYPR (price return, excluding dividends). Past performance does not predict future results.
Are Hyperfine and Vivani Medical in the same industry?
Both are in the Healthcare sector, but in different industries: Medical Devices for Hyperfine and Biotechnology for Vivani Medical.